Application of daffodiline derivatives in the preparation of antibacterial drugs
By developing antibacterial drugs from daffodil derivatives, the problem of drug-resistant strains has been solved, providing effective inhibition against Gram-positive bacteria such as Escherichia coli, Pseudomonas aeruginosa, and Candida albicans, thus achieving an improvement over existing antibiotics.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- JIANGSU VOCATIONAL COLLEGE OF MEDICINE
- Filing Date
- 2021-09-26
- Publication Date
- 2026-06-30
AI Technical Summary
The overuse of existing antibiotics has led to an increase in drug-resistant strains of both Gram-positive and Gram-negative bacteria, and there is a lack of effective antimicrobial drugs without cross-resistance, especially in the treatment of methicillin-resistant Staphylococcus aureus.
Develop dapoxetine derivatives, especially mixed antibacterial drug structures of isochorine and dapoxetine ketone, and prepare them into tablets, capsules, granules or emulsions by combining them with drug carriers or excipients for the purpose of inhibiting Gram-positive bacteria such as Escherichia coli, Pseudomonas aeruginosa and Candida albicans.
This drug exhibits a strong inhibitory effect on Gram-positive bacteria, and in vitro pharmacodynamic experiments show that it has significant antibacterial effects against Escherichia coli, Pseudomonas aeruginosa, and Candida albicans.
Smart Images

Figure SMS_1 
Figure SMS_3 
Figure SMS_4